Jun‐Yang Liou

3.0k total citations
68 papers, 2.5k citations indexed

About

Jun‐Yang Liou is a scholar working on Molecular Biology, Pharmacology and Cell Biology. According to data from OpenAlex, Jun‐Yang Liou has authored 68 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 21 papers in Pharmacology and 14 papers in Cell Biology. Recurrent topics in Jun‐Yang Liou's work include 14-3-3 protein interactions (14 papers), Inflammatory mediators and NSAID effects (14 papers) and Ubiquitin and proteasome pathways (11 papers). Jun‐Yang Liou is often cited by papers focused on 14-3-3 protein interactions (14 papers), Inflammatory mediators and NSAID effects (14 papers) and Ubiquitin and proteasome pathways (11 papers). Jun‐Yang Liou collaborates with scholars based in Taiwan, United States and United Kingdom. Jun‐Yang Liou's co-authors include Kenneth K. Wu, Song‐Kun Shyue, Bor‐Sheng Ko, Yee‐Jee Jan, Shu-Man Liang, Kenneth K. Wu, Tzong‐Shyuan Lee, Lee‐Young Chau, Shu‐Hui Juan and Kuang‐Wen Tseng and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.

In The Last Decade

Jun‐Yang Liou

67 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun‐Yang Liou Taiwan 31 1.6k 494 321 296 287 68 2.5k
Halina Waś Poland 19 1.6k 1.0× 172 0.3× 363 1.1× 281 0.9× 261 0.9× 34 2.2k
Julie C. Holder United Kingdom 23 2.3k 1.4× 279 0.6× 300 0.9× 180 0.6× 266 0.9× 32 3.3k
Marta Casado Spain 28 1.0k 0.6× 283 0.6× 369 1.1× 122 0.4× 167 0.6× 75 2.3k
John Woods United States 28 1.7k 1.0× 430 0.9× 236 0.7× 250 0.8× 502 1.7× 41 3.5k
G. Béréziat France 34 1.4k 0.8× 340 0.7× 316 1.0× 245 0.8× 204 0.7× 148 3.2k
Dipanjan Chanda South Korea 28 1.3k 0.8× 183 0.4× 214 0.7× 307 1.0× 265 0.9× 41 2.4k
X. Charlie Dong United States 31 1.6k 1.0× 172 0.3× 250 0.8× 330 1.1× 150 0.5× 59 3.3k
Jian‐Xiong Chen United States 33 1.2k 0.7× 388 0.8× 475 1.5× 132 0.4× 158 0.6× 94 2.7k
Hong‐Min Ni United States 36 1.9k 1.2× 639 1.3× 271 0.8× 603 2.0× 326 1.1× 73 4.7k
Zongxian Cao United States 23 959 0.6× 502 1.0× 377 1.2× 90 0.3× 286 1.0× 30 2.4k

Countries citing papers authored by Jun‐Yang Liou

Since Specialization
Citations

This map shows the geographic impact of Jun‐Yang Liou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Yang Liou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Yang Liou more than expected).

Fields of papers citing papers by Jun‐Yang Liou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun‐Yang Liou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Yang Liou. The network helps show where Jun‐Yang Liou may publish in the future.

Co-authorship network of co-authors of Jun‐Yang Liou

This figure shows the co-authorship network connecting the top 25 collaborators of Jun‐Yang Liou. A scholar is included among the top collaborators of Jun‐Yang Liou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun‐Yang Liou. Jun‐Yang Liou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Tzu-Ching, Yi-Jhu Lu, Shu-Man Liang, et al.. (2024). The effects of acetylated cordycepin derivatives on promoting vascular angiogenesis and attenuating myocardial ischemic injury. Heliyon. 10(21). e40026–e40026.
2.
Liang, Shu-Man, et al.. (2023). Antrodia cinnamomea Extract Attenuates Cisplatin-Induced Muscle Atrophy, Apoptosis, and Cell Growth Suppression. Journal of Food Biochemistry. 2023. 1–9. 1 indexed citations
3.
Chen, Shufen, et al.. (2023). Surf4 collaborates with derlin-2 and derlin-1 to mediate cyclooxygenase-2 translocation to the cytosol for degradation. Journal of Cell Science. 136(18). 1 indexed citations
4.
Lu, Yi-Jhu, Bor‐Sheng Ko, Tzu-Ching Chang, et al.. (2021). Reduced Expression of Metallothionein-I/II in Renal Proximal Tubules Is Associated with Advanced Chronic Kidney Disease. Toxins. 13(8). 568–568. 6 indexed citations
5.
Liang, Shu-Man, Yi‐Ju Wu, Yi-Jhu Lu, et al.. (2019). Cordycepin Suppresses Endothelial Cell Proliferation, Migration, Angiogenesis, and Tumor Growth by Regulating Focal Adhesion Kinase and p53. Cancers. 11(2). 168–168. 24 indexed citations
6.
Wu, Yi‐Ju, Bor‐Sheng Ko, Shu-Man Liang, et al.. (2019). ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma. Cell Death and Disease. 10(6). 408–408. 22 indexed citations
7.
Liang, Shu-Man, Yi-Jhu Lu, Bor‐Sheng Ko, et al.. (2017). Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity. Scientific Reports. 7(1). 43930–43930. 21 indexed citations
8.
Chang, Tzu-Ching, et al.. (2016). Paracrine regulation of matrix metalloproteinases contributes to cancer cell invasion by hepatocellular carcinoma-secreted 14-3-3σ. Oncotarget. 7(24). 36988–36999. 14 indexed citations
9.
Liu, Tzu-An, Yee‐Jee Jan, Bor‐Sheng Ko, et al.. (2015). Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma. Oncotarget. 6(36). 38967–38982. 21 indexed citations
10.
Liou, Jun‐Yang, et al.. (2015). Prostacyclin protects vascular integrity via PPAR/14-3-3 pathway. Prostaglandins & Other Lipid Mediators. 118-119. 19–27. 33 indexed citations
11.
Wu, Yi‐Ju, Yee‐Jee Jan, Bor‐Sheng Ko, Shu-Man Liang, & Jun‐Yang Liou. (2015). Involvement of 14-3-3 Proteins in Regulating Tumor Progression of Hepatocellular Carcinoma. Cancers. 7(2). 1022–1036. 44 indexed citations
12.
Sung, Li‐Ying, Qian Zhang, Jun‐Yang Liou, et al.. (2014). Telomere Elongation and Naive Pluripotent Stem Cells Achieved from Telomerase Haplo-Insufficient Cells by Somatic Cell Nuclear Transfer. Cell Reports. 9(5). 1603–1609. 12 indexed citations
13.
Ko, Bor‐Sheng, Tzu-An Liu, Shu-Man Liang, et al.. (2014). Cordycepin Suppresses Integrin/FAK Signaling and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Anti-Cancer Agents in Medicinal Chemistry. 14(1). 29–34. 36 indexed citations
14.
Ou, Da‐Liang, et al.. (2014). Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin. Molecular Cancer. 13(1). 2–2. 38 indexed citations
15.
Chen, Bo-Rui, et al.. (2012). Quiescent Fibroblasts Are More Active in Mounting Robust Inflammatory Responses Than Proliferative Fibroblasts. PLoS ONE. 7(11). e49232–e49232. 16 indexed citations
16.
Chang, Tzu‐Ching, Yen‐Chung Chen, Minghua Yang, et al.. (2010). Correction: Rho Kinases Regulate the Renewal and Neural Differentiation of Embryonic Stem Cells in a Cell Plating Density–Dependent Manner. PLoS ONE. 5(3). 8 indexed citations
17.
18.
Liou, Jun‐Yang, et al.. (2008). Nonsteroidal Anti-Inflammatory Drugs Induced Endothelial Apoptosis by Perturbing Peroxisome Proliferator-Activated Receptor-δ Transcriptional Pathway. Molecular Pharmacology. 74(5). 1399–1406. 38 indexed citations
19.
Liou, Jun‐Yang, et al.. (2005). Mitochondrial localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human cancer cells: Implication in apoptosis resistance. Experimental Cell Research. 306(1). 75–84. 60 indexed citations
20.
Wu, Kenneth K. & Jun‐Yang Liou. (2005). Cellular and molecular biology of prostacyclin synthase. Biochemical and Biophysical Research Communications. 338(1). 45–52. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Halina Waś Breakdown of academic impact, for papers by Julie C. Holder Breakdown of academic impact, for papers by Marta Casado Breakdown of academic impact, for papers by John Woods Breakdown of academic impact, for papers by G. Béréziat Breakdown of academic impact, for papers by Dipanjan Chanda Breakdown of academic impact, for papers by X. Charlie Dong Breakdown of academic impact, for papers by Jian‐Xiong Chen Breakdown of academic impact, for papers by Hong‐Min Ni Breakdown of academic impact, for papers by Zongxian Cao
Rankless by CCL
2026